(Total Views: 303)
Posted On: 06/14/2019 12:01:57 PM
Post# of 154930
Thanks again. So all phases of the trial will confirm Leronlimab is safe in patients in combination with current SOC dose of Carboplatin.
That makes sense as we are not testing Carboplatin, except any decreases to Carboplatin doses will be done outside of FDA oversight and at the risk of the doctors and patients? Maybe this is an acceptable risk and will be gradually decreased and with more testing and data and eventually a new combined dosage will be determined for future SOC levels?
I'm not listening to Fortuno's advice and likely losing credibility....but that's the risk when trying to learn something new.
That makes sense as we are not testing Carboplatin, except any decreases to Carboplatin doses will be done outside of FDA oversight and at the risk of the doctors and patients? Maybe this is an acceptable risk and will be gradually decreased and with more testing and data and eventually a new combined dosage will be determined for future SOC levels?
I'm not listening to Fortuno's advice and likely losing credibility....but that's the risk when trying to learn something new.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
